Understanding the medication and its route
Benzathine penicillin G is a repository penicillin formulation designed to release penicillin slowly from the injection site over several weeks. For secondary prevention of rheumatic fever, the goal is to maintain a low but continuous bactericidal level against group A streptococci, which is why a single
deep intramuscular injection of
1.2 million units every
3 to 4 weeks is the standard regimen.
This drug must never be given intravenously because the particulate suspension can cause embolism, severe hypotension, or cardiac arrest if it enters the vascular space directly. Subcutaneous injection is also inappropriate because it causes intense local irritation and does not provide the reliable depot absorption needed for sustained prophylaxis.
Why observation for allergic reaction is the priority
Penicillin is one of the most common causes of drug-induced anaphylaxis. After any penicillin injection, the nurse must observe the client for signs of hypersensitivity such as urticaria, wheezing, stridor, angioedema, or hypotension.
Key point! The observation period is not optional; it is a safety requirement after every dose, even if the client has tolerated previous injections, because sensitization can develop over time. In the context of this client who is already on warfarin for her rheumatic mitral stenosis, any allergic reaction that causes vomiting, syncope, or hemodynamic instability would be especially dangerous because of her underlying valvular disease and anticoagulated state.
Why massage is contraindicated in this client
The client has moderate rheumatic mitral stenosis and atrial fibrillation, which means she is likely receiving warfarin for stroke prevention. Massaging an intramuscular injection site in an anticoagulated client increases the risk of hematoma formation and soft tissue bleeding.
After the injection, firm pressure is applied to the site without massage to minimize bleeding while preserving the depot of medication. Massage would also accelerate systemic absorption of the repository penicillin, which is undesirable because the goal is slow, sustained release over weeks, not a rapid peak.
Comparing the options
| Option | Route or action | Why it is incorrect |
|---|
| 1 | Subcutaneous injection into the abdomen, rotating sites each month | Benzathine penicillin G is not given subcutaneously; it requires deep IM injection into a large muscle mass such as the gluteal or vastus lateralis. Subcutaneous administration causes severe pain, induration, and unreliable absorption. |
| 2 | Deep intramuscular injection, then massage the site firmly for 5 minutes | Massage is contraindicated in a client on warfarin because it promotes bleeding and hematoma. It also disrupts the depot effect by accelerating drug absorption. |
| 3 | Deep intramuscular injection, then watch for an allergic reaction | Correct. This matches the standard route and the essential post-injection safety monitoring for penicillin. |
| 4 | Slow intravenous injection over 5 minutes through her saline lock | Benzathine penicillin G is a suspension and is never given IV. IV administration can cause fatal embolic or anaphylactic reactions. |
Clinical considerations from the evidence
The repository nature of benzathine penicillin G is central to its role in rheumatic fever prophylaxis. The slow release from the IM depot allows dosing every
2 to 4 weeks, although
3 to 4 weeks is the most common interval for secondary prevention in stable clients. Local pain at the injection site is a well-documented drawback of this medication, and some studies have explored using lidocaine as a diluent to reduce discomfort; however, the standard nursing responsibility remains the same: administer deep IM, avoid IV or subcutaneous routes, and monitor for hypersensitivity.
Watch out! A client who reports no prior penicillin allergy can still develop anaphylaxis on a subsequent dose, so every injection requires the same level of vigilance.
Integrating with this client's overall care
This client's rheumatic mitral stenosis places her at ongoing risk for recurrent rheumatic fever if group A streptococcal infection recurs. The secondary prophylaxis with benzathine penicillin G is therefore not a short-term treatment but a long-term preventive strategy. Because she also has atrial fibrillation and is anticoagulated, the nurse must coordinate the injection technique with her bleeding risk.
The correct sequence is deep IM injection, application of firm pressure without massage, and a period of observation for allergic reaction. The observation should be long enough to detect early anaphylaxis, typically at least
15 to 30 minutes after administration, with emergency equipment such as epinephrine readily available.